Combination Chemotherapy with Cisplatin, Pemetrexed, and Nivolumab for Malignant Pleural Mesothelioma: A Trial in Progress

被引:0
|
作者
Fujimoto, N. [1 ]
Aoe, K. [2 ]
Kozuki, T. [3 ]
Oze, I. [4 ]
Kato, K. [5 ]
Kishimoto, T. [1 ]
Hotta, K. [6 ]
机构
[1] Okayama Rosai Hosp, Okayama, Japan
[2] Yamaguchi Ube Med Ctr, Ube, Yamaguchi, Japan
[3] Shikoku Canc Ctr Hosp, Matsuyama, Ehime, Japan
[4] Aichi Canc Ctr, Res Inst, Nagoya, Aichi, Japan
[5] Kawasaki Med Coll, Okayama, Japan
[6] Okayama Univ Hosp, Okayama, Japan
关键词
programmed death-1; immune checkpoint inhibitor; asbestos;
D O I
10.1016/j.jtho.2018.08.1265
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P2.06-10
引用
收藏
页码:S746 / S746
页数:1
相关论文
共 50 条
  • [41] Pemetrexed disodium in combination with cisplatin versus other cytotoxic agents or supportive care for the treatment of malignant pleural mesothelioma
    Green, J.
    Dundar, Y.
    Dodd, S.
    Dickson, R.
    Walley, T.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (01):
  • [42] Triplet chemotherapy with cisplatin, gemcitabine and vinorelbine for malignant pleural mesothelioma
    Maruyama, R
    Shoji, F
    Okamoto, T
    Miyamoto, T
    Miyake, T
    Nakamura, T
    Ikeda, J
    Aoki, Y
    Wataya, H
    Asoh, H
    Ichinose, Y
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2005, 35 (08) : 433 - 438
  • [43] Pemetrexed-cisplatin combination in mesothelioma
    Reck, M
    Gatzemeier, U
    EXPERT REVIEW OF ANTICANCER THERAPY, 2005, 5 (02) : 231 - 237
  • [44] Prospective study of combination chemotherapy with cyclophosphamide, doxorubicin, and cisplatin for unresectable or metastatic malignant pleural mesothelioma
    Anand, A
    Anand, A
    Anand, N
    CANCER, 1996, 77 (09) : 1959 - 1960
  • [45] COMBINATION CHEMOTHERAPY WITH CISPLATIN-VINBLASTINE IN MALIGNANT MESOTHELIOMA
    TSAVARIS, N
    MYLONAKIS, N
    KARVOUNIS, N
    BACOYIANNIS, C
    BRIASOULIS, E
    SKARLOS, D
    PAVLIDIS, N
    STAMATELOS, G
    KOSMIDIS, P
    LUNG CANCER, 1994, 11 (3-4) : 299 - 303
  • [46] Combination chemotherapy with cisplatin and gemcitabine in malignant peritoneal mesothelioma
    Tanida, Satoshi
    Kataoka, Hiromi
    Kubota, Eiji
    Mori, Yoshinori
    Sasaki, Makoto
    Ogasawara, Naotaka
    Wada, Tsuneya
    Mizoshita, Tsutomu
    Shimura, Takaya
    Murakami, Kenji
    Mizushima, Takashi
    Hirata, Yoshikazu
    Okamoto, Yasuyuki
    Mabuchi, Motoshi
    Ebi, Masahide
    Tanaka, Mamoru
    Kamiya, Takeshi
    Takahashi, Satoru
    Joh, Takashi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2009, 14 (03) : 266 - 269
  • [47] Combination chemotherapy with cisplatin and gemcitabine in malignant peritoneal mesothelioma
    Satoshi Tanida
    Hiromi Kataoka
    Eiji Kubota
    Yoshinori Mori
    Makoto Sasaki
    Naotaka Ogasawara
    Tsuneya Wada
    Tsutomu Mizoshita
    Takaya Shimura
    Kenji Murakami
    Takashi Mizushima
    Yoshikazu Hirata
    Yasuyuki Okamoto
    Motoshi Mabuchi
    Masahide Ebi
    Mamoru Tanaka
    Takeshi Kamiya
    Satoru Takahashi
    Takashi Joh
    International Journal of Clinical Oncology, 2009, 14 : 266 - 269
  • [48] S1619 A Trial of Neoadjuvant Cisplatin-Pemetrexed With Atezolizumab in Combination and Maintenance for Resectable Pleural Mesothelioma
    Tsao, A.
    Qian, L.
    Cetnar, J.
    Sepesi, B.
    Gomez, D.
    Wrangle, J.
    Simon, G.
    Mott, F.
    Hall, R.
    Santana-Davila, R.
    Koczywas, M.
    Redman, M.
    Kelly, K.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S870 - S870
  • [49] Chemotherapy for malignant pleural mesothelioma (MPM) in the era of pemetrexed: experience in Northern Ireland
    Campbell, L.
    Scullin, P.
    LUNG CANCER, 2009, 63 : S8 - S8
  • [50] The trimodal Therapy concept of malignant Pleural mesothelioma: Pleurectomy/Decortication, 4 Cycles of Chemotherapy with Cisplatin/Pemetrexed and Radiation.
    Boeluekbas, S.
    Manegold, C.
    Eberlein, M.
    Bergmann, T.
    Fisseler-Eckhoff, A.
    Schirren, J.
    ONKOLOGIE, 2010, 33 : 123 - 123